Accessibility Menu

Yd Bio

(NASDAQ) YDES

Current Price$5.50
Market Cap$382.23M
Since IPO (2020)-48%
5 Year-46%
1 Year-51%
1 Month-38%

Yd Bio Financials at a Glance

Market Cap

$382.23M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.97M

EPS (TTM)

$-0.99

P/E Ratio

-5.49

Dividend

$0.00

Beta (Volatility)

0.12 (Low)

Price

$5.50

Volume

32,232

Open

$6.92

Previous Close

$5.42

Daily Range

$5.40 - $6.92

52-Week Range

$5.30 - $31.00

YDES News

No articles available.

YDES: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Yd Bio

Industry

Biotechnology

Employees

4

CEO

Ethan Shen, PhD, EMBA

Headquarters

Taipei, 115001, TW

YDES Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

17%

Return on Assets

-1%

Earnings Yield

-18.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$382.23M

Shares Outstanding

70.52M

Volume

32.23K

Short Interest

0.00%

Avg. Volume

35.54K

Financials (TTM)

Gross Profit

$155.36K

Operating Income

$1.46M

EBITDA

$1.28M

Operating Cash Flow

$1.84M

Capital Expenditure

$2.91M

Free Cash Flow

$4.75M

Cash & ST Invst.

$3.13M

Total Debt

$22.55K

Yd Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$382.23M

N/A

Market Cap/Employee

$95.56M

N/A

Employees

4

N/A

Net Income

$2.21M

-112.9%

EBITDA

$2.22M

-113.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$6.31K

-84.2%

Accounts Receivable

$53.91K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.01%

N/A

Return on Invested Capital

16.75%

N/A

Free Cash Flow

$298.19K

+49.7%

Operating Cash Flow

$298.19K

+49.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LENZLENZ Therapeutics, Inc.
$11.49-1.96%
PRMEPrime Medicine, Inc.
$3.68+4.25%
TBPHTheravance Biopharma, Inc.
$14.01+1.30%
BTXBlackRock Technology and Private Equity Term Trust
$6.53+0.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
QQQInvesco QQQ Trust
$593.02-0.00%

Questions About YDES

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.